Advertisement
08/01/2022

Dr. Reddy’s debuts generic Velcade

Velcade is used to treat adults with multiple myeloma, a cancer of the plasma cells. It also is used to treat adults with mantle cell lymphoma, a cancer of the lymph nodes.
Sandra Levy
Senior Editor
Sandra Levy profile picture

Dr. Reddy’s is introducing bortezomib for injection 3.5 mg, the generic of Takeda’s Velcade.

Velcade is used to treat adults with multiple myeloma, a cancer of the plasma cells. It also is used to treat adults with mantle cell lymphoma, a cancer of the lymph nodes.

[Read more: Dr. Reddy's intros generic Revlimid in Canada

The Velcade brand and generic had a market value of approximately $1.2 billion for the most recent 12 months ending in May 2022, according to IQVIA.

Dr. Reddy’s bortezomib for injection is supplied in a 3.5 mg per 10 ml single-dose vial presentation for subcutaneous or intravenous use.q[Read more: Dr. Reddy's unveils generic BiCNU]

    Advertisement
    Advertisement